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Received December 24, 2014; accepted April 13, 2015AbstractBackground: The impact of feeding after endoscopic treatment of gastroesophageal varices has rarely been thoroughly investigated. We con-
ducted a controlled study to evaluate whether delayed feeding causes a reduced incidence of rebleeding on patients receiving emergency
endoscopic therapy for bleeding gastroesophageal varices.
Methods: Cirrhotic patients presenting with acute esophageal variceal bleeding were provided critical treatment through emergency endoscopic
variceal ligation. After bleeding from the varices had been arrested, the eligible participants were randomized to two groups. The early-feeding
group and the delayed-feeding group were asked to fast for 4 hours and 48 hours, respectively, after endoscopic therapy. The primary end points
were initial hemostasis, very early rebleeding, and ulcer-bleeding rates.
Results: There were 36 patients enrolled in the early-feeding group and 34 patients in the delayed-feeding group. Both groups were comparable
in baseline data. Initial hemostasis was achieved in 100% in both groups, and very early rebleeding was not encountered in either group. The
incidence of adverse events was similar between both groups. The mean hospitalization days were 6.0 ± 2.4 days (range: 2e17 days) in the
early-feeding group, and 7.5 ± 3.1 days (range: 3e22 days) in the delayed-feeding group ( p < 0.05).
Conclusion: Early feeding with liquid diet after a successful endoscopic therapy of bleeding varices did not have any impact on hemostasis.
Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Acute esophageal variceal hemorrhage is a formidable
complication of portal hypertension, although its management
has evolved rapidly in recent years.1,2 Vasoconstrictors are
generally used as a first-line therapy. Following the use of a
vasoconstrictor, endoscopic therapy is often employed to arrest
the bleeding varices as well as to prevent early rebleeding. A
meta-analysis showed that the combination of vasoconstrictorConflicts of interest: The authors declare that there are no conflicts of interest
related to the subject matter or materials discussed in this paper.
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in the control of acute esophageal variceal hemorrhage.3 Pre-
vious studies showed that endoscopic variceal ligation (EVL)
is superior to endoscopic injection sclerotherapy (EIS) in the
control of active variceal hemorrhage.4,5 It is thus recom-
mended that EVL is the endoscopic treatment of choice for
acute esophageal variceal bleeding.5 Moreover, apart from the
control of acute variceal bleeding, the use of prophylactic
antibiotics has been proven to be helpful in the prevention of
bacterial infection as well as early variceal rebleeding.6
Currently, the combination of vasoconstrictors, prophylactic
antibiotics, and EVL has become the standard of therapy for
patients with acute esophageal variceal bleeding.
On the other hand, a high incidence of early rebleeding may
be encountered after combination therapy. It is estimated thatociation. All rights reserved.
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bleeding, which in turn leads to a high mortality rate.7,8 The
impact of feeding after endoscopic treatment of gastroesoph-
ageal varices has rarely been well investigated. It is still un-
known whether those early rebleeding events have any relation
to the feedings of patients with acute esophageal variceal
bleeding treated with EVL. It is customary for clinicians to
institute absolute fasting for 2 or 3 days after an emergency
EVL. This may presumably be a safe approach to guard
against the occurrence of early rebleeding. However, pro-
longed fasting may be unethical to patients who have a low
risk of rebleeding. Moreover, prolonged fasting may lead to
impaired nutrition and development of ascites in cirrhotic
patients, possibly resulting in an increased length of hospi-
talization. Thus, we conducted a controlled study to evaluate
whether delayed feeding has a reduced incidence of rebleeding
on patients receiving emergency endoscopic therapy for
bleeding gastroesophageal varices.
2. Methods
Between March 2011 and December 2012, patients pre-
senting with acute gastroesophageal variceal bleeding proven
by emergency endoscopy within 12 hours were considered for
enrollment. Other enrolled criteria were (1) the etiology of
portal hypertension was cirrhosis; (2) patients between 20 and
80 years of age; (3) EVL was performed after confirmation of
acute esophageal variceal bleeding, and Histoacryl injection
was performed if acute gastric variceal bleeding was diag-
nosed; and (4) variceal bleeding was arrested on the spot by
emergency endoscopic therapy.
Acute esophageal variceal bleeding was defined as (1)
when blood was directly seen by endoscopy to issue from an
esophageal varix (active bleeding), or (2) when patients pre-
sented with red color signs or blood clots on their esophageal
varices with blood in the esophagus or stomach, and no other
potential site of bleeding has been identified (inactive
bleeding).8 Gastric variceal bleeding was defined as active
spurting from a gastric varix or the presence of red spots and
erosions on a gastric varix.9 The diagnosis of cirrhosis was
based on history, physical examinations, liver histology, or
image studies. Our methods of emergency EVL and Histoacryl
injection have been described previously in detail.8e10 Briefly,
ligation was initiated at the bleeding point, hematocystic spots
or white nipple signs if present, or at gastroesophageal junc-
tion, and advanced proximally. The obturation agent for gastric
varices was 0.5 mL n-butyl-2-cyanoacrylate (Histoacryl; B.
Braun Melsungen AG, Melsungen, Germany) mixed with
0.5 mL Lipiodol Ultra-Fluide (Guerbet, Bois Cedex, France).
The injection sites were focused at either the bleeding site or
the hematocystic spots, or the erosive spots on the culprit varix.
After completion of EVL or gastric variceal obturation, water
irrigation was performed to ensure hemostasis was achieved.
The exclusion criteria were (1) association with a severe
systemic illness, such as sepsis, uremia, advanced hepatocel-
lular carcinoma (HCC), and HCC staging > Barcelona-Clínic
Liver Cancer B; (2) failure to control variceal bleeding byemergency endoscopic therapy; (3) uncooperative or on
endotracheal intubation; (4) ever received EIS or EVL within
1 month prior to index bleeding; (5) ChildePugh's scores >13;
(6) deep jaundice (serum bilirubin >10 mg/dL) and presence
of encephalopathy > stage II or massive ascites; and (7)
refusal to participate.
The eligible participants continued to receive vasocon-
strictor for 3 days (either terlipressin or somatostatin) and
prophylactic antibiotics for 5 days (cefazolin or cefotaxime).
Lactulose was administered to patients with blood or coffee-
ground-like materials in the stomach. The eligible participants
were randomized to two groups: the early-feeding group and
the delayed-feeding group. Randomization was based on a
table of random numbers in a sealed envelope. Enrollment was
done immediately after endoscopic treatment was completed
and variceal bleeding was arrested. Patients in the early-feeding
group were asked to fast for only 4 hours following endoscopic
treatment. Subsequently, a liquid diet (fruit juice, soybean
juice, milk, rice in liquid form) was instituted for 3 days.
Additionally, <500 cc intravenous fluid with proper electrolyte
supplement per day was administered. Thereafter, a soft diet
was provided for 3 days, after which a regular diet was resumed
since the seventh day after endoscopic treatment. Patients in the
delayed-feeding group were asked to absolutely fast for 48
hours after endoscopic treatment, and 1500 cc/day intravenous
fluids (normal saline or glucose water) with proper electrolytes
were administered for 2 days. After 2 days of fasting, a liquid
diet was given for 1 day, and subsequently, a soft diet was given
for 3 days, and then a regular diet was instituted on the seventh
day after endoscopic treatment. If rebleeding occurred within 7
days of endoscopic therapy, patients in both groups were again
asked to fast for 48 hours, and then put on a liquid diet for 1
day followed by a soft diet for 4 days.
The definitions of treatment failure, very early rebleeding,
initial hemostasis, and 5-day hemostasis were similar to those
described previously.11
Treatment failure was defined as failure to control acute
bleeding episodes or very early rebleeding or death within 5
days. Failure to control acute variceal bleeding was defined as
the occurrence of any of the following events within 48 hours
of enrollment, based on the modified criteria of the Baveno III
consensus:11 (1) fresh hematemesis after enrollment; (2) sud-
den onset of reduction in blood pressure of 20 mmHg and/or
an increase in pulse rate of 20 beats/minute with 2 g drop in
hemoglobin; (3) transfusion of four units of blood required to
increase the hematocrit to above 27% or hemoglobin to above
9 g/dL; and (4) death. Very early rebleeding was defined as
when the criteria for failure to control acute variceal bleeding
occurred between 48 hours and 120 hours after enrollment in
patients achieving control of acute bleeding. Control of acute
bleeding (initial hemostasis) was defined as when the criteria
for failure did not occur within 48 hours of enrollment. A 5-
day hemostasis was defined as when the criteria for failure
to control acute variceal bleeding and very early rebleeding
did not occur within 5 days of enrollment. A nasogastric tube
was not routinely inserted after initial endoscopy. However, a
nasogastric tube was inserted in cases of failure to control
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control acute bleeding and very early rebleeding were assessed
by two experienced clinicians. Patients with failure of initial
hemostasis or very early rebleeding were treated with a
vasoconstrictor, a proton pump inhibitor, and EVL or balloon
tamponade as clinically indicated.
At the time of enrollment, the severity of the liver disease
was classified according to ChildePugh's classification12 and
the model-for-end-stage-liver-disease score.13 The sizes of the
esophageal varices were classified according to Beppu et al's14
criteria. After the patients were hospitalized for more than 5
days, the surviving patients in both groups received regular
EVL and beta-blockers to prevent rebleeding.15 All the patients
received abdominal ultrasound to detect the presence of ascites
or liver tumor on enrollment. Newly developed ascites, infec-
tion, and hospitalization days were recorded. The detection of
newly developed ascites after enrollment was performed by the
use of ultrasound on clinical suspicion of ascites. Blood and
frozen plasma transfusion and albumin infusion were admin-
istered to patients in both groups as clinically indicated. All the
patients signed an informed consent. Our study was approved
by the institution of review board at our hospital.
Emergency endoscopy was performed to detect the
bleeding source if rebleeding occurred, and vasoconstrictors
were administered. If ulcer bleeding was noted, a proton pump
inhibitor was given for 8 weeks. The primary end points were
the success rate of the initial hemostasis, very-early-rebleeding
rate, and ulcer-bleeding rate. The secondary end points
included the amounts of blood transfusion, new development
of ascites, hospitalization days, and mortality within 42 days.2.1. Sample-size calculation and statistical analysisA meta-analysis showed that the hemostatic rate of endo-
scopic therapy alone in the control of acute variceal bleeding
was 58%, and the combination of vasoconstrictor and endo-
scopic therapy was 77%.3 Generally, the hemostatic rate of
endoscopic treatment plus vasoconstrictor is nowadays around
80e90%.2 The 5-day hemostatic rate may also be as low as
66%.16 We presumed that the hemostatic rate was 90% in
patients not allowed to take food for 48 hours after endoscopic
treatment (delayed feeding), and 65% in individuals allowed
to take food since 4 hours after endoscopic treatment (early
feeding), and approximately 35 participants would be required
for each group with a two-tailed test to achieve a beta value of
0.1 and an a error of 5%. The data were expressed as
mean ± standard deviation. The statistical analysis was based
on an intention-to-treat principle. The quantitative variables
were compared according to Student t test, and the qualitative
variables were compared with the Chi-square test and Fisher's
exact test when appropriate. All p values were two tailed. A
p < 0.05 was considered significant.
3. Results
A total of 133 patients were screened, and 63 patients were
excluded arising from HCC (24 patients), greater than 80 yearsold (8 patients), chronic renal failure (7 patients), respiratory
failure (2 patients), deep jaundice (4 patients), failure to arrest
acute variceal bleeding (8 patients), and refusal to participate
(10 patients). Finally, 70 patients were enrolled in the trial: 36
patients in the early-feeding group and 34 patients in the
delayed-feeding group (Fig. 1). Both groups were comparable
in baseline characteristics, such as etiologies of cirrhosis,
severity of liver disease as shown by ChildePugh's class and
model-for-end-stage-liver-disease scores, severity of esopha-
geal varices, proportion of active bleeding, the use of vaso-
constrictors, and the amount of blood transfusion before
endoscopic therapy (Table 1). No participants were lost to
follow-up.
The main outcomes are shown in Table 2. The rubber bands
applied to treat acute variceal bleeding were similar in both
treatment groups. Treatment failure or failure in the control of
acute bleeding was not encountered in each treatment group.
In the early-feeding group, one patient rebled on the 27th day.
Three patients in the delayed-feeding group rebled on 12 days,
14 days, and 27 days after endoscopic therapy, respectively.
Two of these patients presented with active variceal bleeding
at index endoscopy. All these patients were successfully
rescued with a vasoconstrictor and repeated EVL. The pro-
portion of patients receiving beta-blockers and the mean dose
of carvedilol was similar between both groups (Table 2).
Adverse events, including ulcer bleeding in one patient,
abdominal pain in one patient, bacterial infection in three
patients (one with bacteremia and two patients with urinary
tract infection), and fever in seven patients, were noted in the
early-feeding group. In the delayed-feeding group, two pa-
tients had abdominal pain, two patients had dysphagia, two
patients had bacterial infection, and six patients had fever. No
significant differences existed between both treatment groups.
No patients developed aspiration pneumonia.
The amount of blood transfusion was similar between both
groups. On enrollment, 15 patients in the early-feeding group
and 14 patients in the delayed-feeding group had ascites.
Newly developed ascites were noted to occur in three patients
in the early-feeding group and six patients in the delayed-
feeding group ( p ¼ 0.24). The mean hospital stay was
6.0 ± 2.4 days (range: 2e17 days) in the early-feeding group,
and 7.5 ± 3.1 days (range: 3e22 days) in the delayed-feeding
group ( p < 0.05). Two patients in the delayed-feeding group
died of sepsis on 22 days and 42 days after enrollment,
respectively. The survival at 6 weeks after variceal bleeding
was similar between both treatment groups.
4. Discussion
Following endoscopic therapy of variceal bleeding, the
issue of when to refeed these patients has rarely been inves-
tigated. This may imply that feeding is generally regarded as a
negligible factor in the management of bleeding varices. On
the other hand, it is usually believed that systematic fasting is
required in case of patients with upper gastrointestinal
bleeding.17 The main reason of delay in feeding may be
ascribed to the fear of occurrence of early rebleeding induced
Table 1
Baseline data of both groups.
Early-feeding
group (n ¼ 36)
Delayed-feeding
group (n ¼ 34)
p
Age (y) 47.5 ± 12.6 53.2 ± 11.8 0.60
Male/female 31/5 28/6 0.74
Etiologies 0.50
Alcohol 19 17
HBV 7 5
HCV 7 12
HBV þ HCV 3 0
Albumin (g/L) 3.0 ± 0.5 3.1 ± 0.6 0.85
Bilirubin (mg/dL) 2.2 ± 1.6 2.5 ± 1.9 0.62
Prothrombin time,
prolongation (s)
2.9 ± 2.2 3.1 ± 2.0 0.75
Ascites 15 14 > 0.99
Encephalopathy 1 (2%) 1 (2%) > 0.99
ChildePugh score 7.6 ± 1.8 8.2 ± 2.2 0.30
ChildePugh (A/B/C) 10/14/12 11/17/6 0.55
Hemoglobin (g/dL) 8.5 ± 2.3 9.0 ± 2.3 0.66
Creatinine (mg/dL) 1.1 ± 0.3 1.1 ± 0.4 0.95
MELD score 12.4 ± 3.7 13.3 ± 4.2 0.62
Size of esophageal varices
F1/F2/F3 6/22/8 5/22/7 0.90
Gastric variceal bleeding 4 3 > 0.99
Active variceal bleeding 11 (31%) 7 (21%) 0.19
Terlipressin/somatostatin 36/1 33/1 > 0.99
Presence of hepatocellular
carcinoma
6 (16%) 7 (26%) 0.76
Blood transfusion (units) 3.1 ± 2.3 2.7 ± 2.2 0.50
HBV ¼ hepatitis B virus; HCV ¼ hepatitis C virus; MELD ¼ model for end-
stage liver disease.
Assessed for 
eligibility (n=133)
Excluded (n=63)
Hepatocellular carcinoma: 24; >80 years old: 8; 
Uremia: 7; respiratory failure: 2; deep jaundice: 4; 
Failure to control of index bleeding: 8;
Refused to participate: 8
Randomized (n=70)
Allocated to intervention
Early feeding
n= 36
Allocated to intervention
Delayed feeding
n= 34
Lost to follow-up (n=0)
Discontinued intervention (n=0)
Lost to follow-up (n=0)
Discontinued intervention (n=0)
Analyzed (n=36)
Excluded from analysis (n=0)
Analyzed (n=34)
Excluded from analysis (n=0)
Fig. 1. A flowchart of patient allocation.
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and therapy may be required in patients with very early
rebleeding. The decision to delay feeding is usually based on
clinicians' experience or experts' opinion rather than evidence
based.17,18 That was why we performed this controlled study.
Nowadays, EVL has replaced EIS as the endoscopic ther-
apy of choice for acute esophageal variceal bleeding.1,4,5
Stiegmann and Goff19 were the first to employ EVL to treat
esophageal varices. They did not mention any specific re-
striction of feeding on patients receiving band ligation.
Following the band ligation of varices, the ligated varices and
tissues may evoke transient dysphagia to solid food.4,19 The
rebleeding rates associated with EVL varied greatly between
studies, and rates ranging from 2% to 54% have been recor-
ded.1,2,20,21 Aside from other reasons, this discrepancy is veryTable 2
Main outcomes in the two treatment groups.
Early-feeding
group (n ¼ 36)
Delayed-feeding
group (n ¼ 34)
p
Rubber bands 3.5 ± 0.5 (2e5) 3.2 ± 0.6 (3e5) 0.75
Treatment failure 0 0 > 0.99
Failure to control
acute bleed
0 0 > 0.99
Very early rebleeding 0 0 > 0.99
Use of beta-blockers 8 (22%) 10 (29%) 0.49
Dose of carvedilol (mg/d) 10.9 ± 1.5 10.6 ± 1.7 0.85
Rebled between 6 d and 42 d 1 (3%) 3 (8.8%) 0.34
Hospital stay (d) 6.0 ± 2.4 7.5 ± 3.1 <0.05
Blood transfusion (units)
after endoscopy
1.83 ± 1.25 2.15 ± 1.60 0.70
42-d mortality 0 2 (6%) 0.49
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EVL. However, this factor was rarely mentioned in the
methodology of these studies.
Previously, Laine et al22 have demonstrated that immediate
refeeding has similar outcomes to delayed refeeding among
patients with low risk of nonvariceal bleeding. The situation of
variceal bleeding is quite different from that of peptic ulcer
bleeding. Hebuterne and Vanbiervliet17 made a review on
feeding of patients with upper gastrointestinal bleeding, and
recommended that feeding should be delayed for at least 48
hours after endoscopic therapy because early refeeding may
cause a shift in blood flow to the splanchnic circulation, which
in turn could lead to an increase in pressure and an increased
risk of rebleeding from the varices.
Our study included cirrhotic patients with acute variceal
bleeding, both active bleeding and inactive bleeding at
endoscopy. Our results revealed that early feeding with a
liquid diet as early as 4 hours after endoscopic therapy did not
enhance rebleeding as compared with patients with delayed
feeding for 48 hours. The adoption of lagging 4 hours after
EVL in the early-feeding group was anticipation for emptying
of old blood in the stomach by the use of lactulose. Patients
with active variceal bleeding are generally predisposed to have
an appreciably high incidence of early rebleeding.1,2,23,24 The
policy of early feeding also did not have any impact on our
patients presenting with active bleeding at endoscopic therapy.
Our study also enrolled some patients with gastric variceal
bleeding who were treated with Histoacryl injection. Similar
to previous observations,2,9,10,21,25 the current study showed
that both EVL and gastric variceal obturation with Histoacryl
are highly effective in the control of esophageal and gastric
varices, respectively. Among 133 patients screened for
enrollment, only eight patients (6%) failed in endoscopic he-
mostasis. After a successful endoscopic therapy, failure to
control acute bleeding as well as very early rebleeding was not
encountered in both early-feeding and delayed-feeding groups.
We did not measure portal blood flow and portal pressure;
thus, we could not know whether early feeding with a liquid
diet resulted in an enhanced portal blood flow. However, no
treatment failure evoked by early feeding with a liquid diet at
least reflected that the impact of early feeding on portal blood
flow and portal pressure did not translate to bad clinical out-
comes. Only a study has evaluated enteral nutrition in cirrhotic
patients with bleeding from esophageal varices, and showed
that 33% of patients with early enteral nutrition rebled
compared with the figure of 10% in patients fasting for 3
days.26 Owing to a small sample size (i.e., only 22 patients
were enrolled), no statistical significant difference was
reached. However, they concluded that nasogastric-tube
feeding may be deleterious on the short-term evolution of
bleeding.26 Based on our study, early oral feeding with a liquid
diet may be instituted in patients with successful endoscopic
hemostasis of either esophageal or gastric varices. However,
solid food is still not encouraged in the first few days after
banding ligation of varices. This is to prevent food impaction
in the esophagus, as well as to guard against the occurrence of
very early rebleeding. The clinical outcomes regardingrebleeding rates, mortality, and adverse events were similar in
both groups. However, hospitalization days could be signifi-
cantly shortened in those patients with early refeeding. The
incidence of new development of ascites was slightly lower in
patients with early refeeding. Possibly, a larger sample size is
required to detect the difference. These findings proved that
early feeding with a liquid diet was rather safe. It was
demonstrated that up to 60% of decompensated cirrhotic pa-
tients were noted to have malnutrition.27 Prolonged fasting
may be detrimental to these patients. Early feeding in patients
with successful endoscopic hemostasis of variceal bleeding
has the advantages of increase in patients' satisfaction of desire
for feeding, supply of more calories, shortening of hospital
stay, and a possible decrease of ascites development. Our
patients resumed a regular diet after 7 days of EVL. The safety
of early resumption of a regular diet or solid foods remains to
be investigated. The strengths of the current study include that
this is the first randomized controlled trial to assess the impact
of foods on hemostasis of variceal hemorrhage. Our study has
several limitations. First, the sample size may be not enough.
Up to now, there have been no available data that could be
cited as a reference to estimate the required sample size. The
calculation of the sample size was based on previous reports of
5-day hemostasis by a combination of EVL and vasocon-
strictors (i.e., in the order of 66e100%).4,16,20 We thus pre-
sumed that the hemostasis may be better in the delayed-
feeding group and may be worst in the early-feeding group.
Unexpectedly, both groups achieved 100% 5-day hemostasis.
This may truly reflect that early feeding with a liquid diet does
not have any bad impact on hemostasis, rather than ascribed to
an inadequacy of sample size. Second, factors, such as the
caloric intake, and the amount of liquid diet and solid foods,
were not assessed in this trial. If an adequate caloric intake
could be provided in the first few days after endoscopic
therapy, this would be quite helpful for cirrhotic patients.
In conclusion, our study demonstrated that early feeding
with a liquid diet in conscious patients after successful
endoscopic therapy of varices can shorten the hospital days.
However, we still need a larger sample size to investigate the
impact between early feeding and hemostasis of variceal
bleeding.
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